Finance

Beta
Lists
IMMX:NASDAQ
Immix Biopharma Inc
$10.34
+5.19%
(+0.51) 1D
$10.34
0.00% (0.00)
After hours
Closed: Jul 2, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMMX...
Open
$9.87
High
$10.46
Low
$9.74
Mkt. cap
721.63M
Avg. vol.
2.07M
Volume
2.07M
52-wk high
$11.61
52-wk low
$1.94
EPS
-$0.91
Beta
0.09
Shares outstanding
71.19M
No. of employees
21
Open
$9.87
High
$10.46
Low
$9.74
Mkt. cap
721.63M
Avg. vol.
2.07M
Volume
2.07M
52-wk high
$11.61
52-wk low
$1.94
EPS
-$0.91
Beta
0.09
Shares outstanding
71.19M
No. of employees
21
News stories
From sources across the web
About Immix Biopharma Inc
CEO-
Employees21
Founded2012
HeadquartersLos Angeles, California, United States
SectorBiotechnology
Websiteimmixbio.com
Analyst ratings
Based on 4 analysts giving stock ratings to IMMX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for IMMX in the last 3 months.
Highest
Current $10.34
$27.00 (+161.12%)
Average
$20.25 (+95.84%)
Lowest
$15.00 (+45.07%)
Analyst
Recommendation
Action
Price target
Projected
Date
Tazeen Ahmad
Bank of America Securities
Buy
Initiated
$27.00
+161.1%
06/18/2026
Patrick Dolezal
LifeSci Capital
Buy
Initiated
$19.00
+83.8%
06/17/2026
Graig Suvannavejh
Mizuho Securities
Buy
Maintained
$15.00
+45.1%
05/26/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
$20.00
+93.4%
05/22/2026
Judah Frommer
Morgan Stanley
Buy
Reiterated
$20.00
+93.4%
03/26/2026
Reni Benjamin
Citizens JMP
Buy
Initiated
$23.00
+122.4%
03/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.97M
4.58M
5.73M
5.98M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.75M
3.08M
5.17M
4.82M
Operating expense
6.72M
7.66M
10.89M
10.80M
Total operating expenses
6.72M
7.66M
10.89M
10.80M
Operating income
-6.72M
-7.66M
-10.89M
-10.80M
Other non operating income
-
-
-
-
EBT including unusual items
-6.61M
-7.58M
-10.68M
-10.09M
EBT excluding unusual items
-6.61M
-7.58M
-10.68M
-10.09M
Income tax expense
8.91K
7.72K
11.27K
-
Effective tax rate
-0.13%
-0.10%
-0.11%
-
Other operating expenses
-
-
-
-
Net income
-6.62M
-7.59M
-10.69M
-10.09M
Net profit margin
-
-
-
-
Earnings per share
-0.22
-0.24
-0.28
-0.18
Interest and investment income
104.06K
84.54K
216.71K
717.17K
Interest expense
-
-
-
-
Net interest expenses
104.06K
84.54K
216.71K
717.17K
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.66M
-7.57M
-10.84M
-10.71M
Gain or loss from assets sale
-
-
-
34.15K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer